Trial Profile
Efficacy and safety of 5-Azacytidine combined with donor lymphocyte infusions in hematological relapse after allografting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2015
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 27 May 2015 New trial record